Dr. Mark Pinkowski is a Downers Grove, Illinois based male podiatrist who is specialized in Podiatry. Active license number of Dr. Mark Pinkowski for Podiatry is 016.005902 in Illinois. Dr. Mark Pinkowski is qualified with a Doctor of Podiatric Medicine (D.P.M.) degree, licensed by the state, and practicing within the scope of that license. He diagnose and treat foot diseases and deformities. He can perform medical, surgical and other operative procedures, prescribe corrective devices and prescribe and administer drugs and physical therapy.
Complete Profile:
Dr. Mark Pinkowski speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Podiatrist
Credentials:
DPM
Gender:
Male
Practice Address:
1228 Ogden Ave, Downers Grove, Illinois, 60515-2740
Phone:
773-319-7872
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790208627
NPI Enumeration Date:
23 Jul, 2017
NPI Last Update On:
12 Aug, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Mark Pinkowski are as mentioned below.
License Number
Specialization
State
Status
016.005902
Podiatry
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1228 Ogden Ave, Downers Grove, Illinois
Zip:
60515-2740
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Mark Pinkowski at 1228 Ogden Ave, Downers Grove, Illinois or can call to book an appointment on 773-319-7872. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.